Tag:

Prolong Pharmaceuticals

Latest Headlines

Prolong Pharma lands $30M from investors

October 14, 2010

South Plainfield, NJ-based Prolong Pharmaceuticals says it snared $30 million in financing from unnamed investors. The company is pursuing new anemia therapies. "As we move toward the clinic with our

THE LIBRARY: WEBINAR

Getting the most PoC data in Phase I cancer studies

| June 12, 11am ET/ 8am PT

The hunt for proof-of-concept data is steadily moving upstream in the clinic. Join FierceBiotech on June 12th as three clinical trial experts tackle the question of how you can best design a Phase I study to get a readout on efficacy. Topics will include: enrollment, dosing and the best possible use of biomarkers for experimental cancer drugs. Register Today!

MORE ITEMS

EVENTS

MDMA Annual Meeting May 30th - June 1st, 2012 — Washington, DC
Clinical Trials Eastern Europe Webinar SeriesMay 15-June 12 — Eastern Europe
What's your BIO?June 18-21, 2012 — Boston, MA

MORE EVENTS

Press Releases

Featured Jobs

Entry Level Process Engineer and Lead Process Engineer
Foster Wheeler Biokinetics - San Francisco, CA
Biostatistician (Entry Level) - Permanent Job
Yoh - Tarrytown, NY, USA
Senior Controls Engineer Job
Celgene Corporation - Phoenix, AZ, US
Neurosciences Knowledge Group Lead
Merck - Rahway, NJ - Kenilworth, NJ - West Point, PA - Boston, MA
Director, Marketing IBS Franchise
Prometheus - San Diego, CA

Prolong Pharmaceuticals

Latest Headlines

Latest Headlines

Prolong Pharma lands $30M from investors

THE LIBRARY: WEBINAR

EVENTS

Press Releases

Featured Jobs

A publication of FierceMarkets

The FierceMarkets Network:

Telecom

Healthcare

Government

Energy

Life Sciences

Enterprise IT

Finance

Prolong Pharmaceuticals

Latest Headlines

Latest Headlines

Prolong Pharma lands $30M from investors

Related Tags